2020
Diagnostic Reliability, Accuracy and Safety of Ultrasound-guided Biopsy and Ascites Puncture in Primarily Inoperable Ovarian Tumours
VLASÁK, Pavel, Jiří BOUDA, Jan KOSTUN, Denis BEREZOVSKIY, Michal ZIKÁN et. al.Základní údaje
Originální název
Diagnostic Reliability, Accuracy and Safety of Ultrasound-guided Biopsy and Ascites Puncture in Primarily Inoperable Ovarian Tumours
Autoři
VLASÁK, Pavel (203 Česká republika), Jiří BOUDA (203 Česká republika), Jan KOSTUN (203 Česká republika), Denis BEREZOVSKIY (203 Česká republika), Michal ZIKÁN (203 Česká republika), Vít WEINBERGER (203 Česká republika, domácí), Ondrej ONDIC (203 Česká republika), Zdeněk RUŠAVÝ (203 Česká republika), Radek KUČERA (203 Česká republika), Ondřej TOPOLČAN (203 Česká republika), Zdeněk NOVOTNÝ (203 Česká republika) a Jiří PRESL (203 Česká republika, garant)
Vydání
Anticancer Research, Athens, Greece, 2020, 0250-7005
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30204 Oncology
Stát vydavatele
Řecko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 2.480
Kód RIV
RIV/00216224:14110/20:00115742
Organizační jednotka
Lékařská fakulta
UT WoS
000538104800060
Klíčová slova anglicky
Tru-Cut biopsy; ovarian cancer; ascites; puncture
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 1. 4. 2021 14:08, Mgr. Tereza Miškechová
Anotace
V originále
Background/Aim: To compare the diagnostic reliability, accuracy and safety of ultrasound-guided biopsy (Tru-Cut biopsy) and ascites puncture in patients with a primarily inoperable malignant ovarian tumor. Patients and Methods: This is a retrospective analysis of the studied methods in consecutively examined patients and a prospective validation of these methods. 79 women with a suspected primarily inoperable ovarian tumor underwent Tru-Cut biopsies and were included in the ultrasound-guided biopsy group. In addition, 55 patients after ascites puncture were enrolled in the comparison group. Both procedures were performed in 48 patients for the prospective validation. Results: Significant differences in favour of ultrasound-guided biopsy were found in all studied variables (malignancy confirmation 72.9% vs. 95.8%, tumor origin 52.1% vs. 89.6%, histologic subtype 43.8% vs. 85.4% and accuracy, i.e. agreement of preoperative and definitive diagnosis 43.7% vs. 95.4%). Conclusion: Ultrasound-guided biopsy is an accurate, reliable, safe and minimally invasive method. Owing to the high reliability and accuracy, it has the capacity to replace ascites puncture with cytologic examination or a more invasive method (laparoscopy, laparotomy) for adequate tumor sampling.